| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc. (NUVL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.38M | $170.65M | - | |
| CEO | 324.9K | $40.10M | - | |
| CFO | 99.2K | $12.25M | - | |
| Other | 86.8K | $10.72M | -5,500 | |
| Other | 83.4K | $10.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $75.87 | $2,048,561.73 | -3.4% | -0.9% | +28.5% | |
| Mar 7, 2025 | Noci Darlene | Chief Development Officer | Sale+OE | 34,000 | $71.87 | $2,443,578.02 | -11.1% | +9.9% | +39.8% | |
| Feb 24, 2025 | Shair Matthew45 | Director | Sell | 2,000 | $78.43 | $156,863.60 | -0.3% | -7.4% | +34.4% | |
| Feb 18, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $78.46 | $2,118,336.00 | -5.1% | -7.4% | +29.3% | |
| Jan 27, 2025 | Shair Matthew45 | Director | Sell | 2,000 | $82.79 | $165,575.90 | -0.2% | -8.9% | +28.9% | |
| Jan 15, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $75.99 | $2,051,777.37 | -2.5% | -8.6% | +37.1% | |
| Jan 6, 2025 | Pelish Henry E.61 | Chief Scientific Officer | Sell | 2,483 | $79.68 | $197,853.82 | -1.3% | -17.2% | +24.5% | |
| Jan 6, 2025 | Noci Darlene | Chief Development Officer | Sell | 4,016 | $79.68 | $320,009.01 | -2.6% | -17.2% | +24.5% | |
| Jan 6, 2025 | Miller Deborah Ann | Chief Legal Officer | Sell | 2,964 | $79.68 | $236,182.46 | -1.9% | -17.2% | +24.5% | |
| Jan 6, 2025 | Turner Christopher Durant | Chief Medical Officer | Sell | 4,016 | $79.68 | $320,009.01 | -2.0% | -17.2% | +24.5% |